Holly Hagan
Holly Hagan
Professor Emeritus
-
Professional overview
-
Dr. Holly Hagan is Professor Emeritus at the School of Global Public Health. Trained as an infectious disease epidemiologist, Dr. Hagan’s work has sought to understand the causes and consequences of substance use disorders. Her research has examined blood-borne and sexually-transmitted infections among people who use drugs. She is an internationally-recognized expert in the etiology, epidemiology, natural history, prevention and treatment of hepatitis C virus infection among PWUD, and in 2014 her work was recognized by the US Department of Health and Human Services with the President’s Award for Leadership in the Control of Viral Hepatitis in the United States. Dr. Hagan served on the Institute of Medicine Committee on the Prevention and Control of Viral Hepatitis in the United States, and she has been an advisor to the US Department of Health and Human Services, the CDC, and the Canadian Institutes of Health on national programs to detect, diagnose and treat HCV infections. She was recently appointed to the National Academy of Medicine Committee on the Examination of the Integration of Opioid and Infectious Disease Prevention Efforts in Select Programs.
Dr. Hagan is the Director of the NIDA P30 Center for Drug Use and HIV|HCV Research at Global Public Health, which provides research support to investigators throughout NYU and in two other NYC institutions. In 2017, she was selected by NIDA to chair the Executive Steering Committee for the Rural Opioid Initiative funded by NIH, CDC, SAMHSA and the Appalachian Regional Commission. Her research has shifted to examining the impact of the opioid crisis more broadly, to include studying the epidemiology of fatal and non-fatal overdose among PWUD. She was chosen by the American Foundation for AIDS Research to be the Principal Investigator for the New York State Opioid Prevention Center pilot study, which will examine the safety and effectiveness of the Supervised Consumption Sites to be implemented in New York City and in upstate NY.
-
Education
-
PhD Epidemiology, University of Washington, Seattle, WAMPH Epidemiology, University of Massachusetts, Amherst, MABA Russian Studies, Evergreen State College, Olympia, WA
-
Publications
Publications
Self-reported hepatitis C virus antibody status and risk behavior in young injectors
Failed retrieving data.Social structural and behavioral underpinnings of hyperendemic hepatitis C virus transmission in drug injectors
Failed retrieving data.Staff perspectives on facilitating the implementation of hepatitis C services at drug treatment programs
Failed retrieving data.Using latent class analysis to identify patterns of hepatitis C service provision in drug-free treatment programs in the U.S.
Failed retrieving data.Drug abuse and the spread of infection : HIV and AIDS as an example
Failed retrieving data.Factors associated with interest in initiating treatment for hepatitis C virus (HCV) infection among young HCV-infected injection drug users
Failed retrieving data.Hepatitis C Among Intravenous Drug Users
Failed retrieving data.Hepatitis C among intravenous drug users [6] (multiple letters)
Failed retrieving data.Hepatitis C Service Delivery in Prisons : Peer Education From the “Guys in Blue”
Failed retrieving data.HIV/hepatitis C virus co-infection in drug users : Risk behavior and prevention
Failed retrieving data.Integrating hepatitis C services into existing HIV services : The experiences of a sample of U.S. drug treatment units
Failed retrieving data.Medical examinations at entry to treatment for drug abuse as an opportunity to initiate care for hepatitis C virus infection
Failed retrieving data.Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001
Failed retrieving data.Residential substance user treatment programs as venues for HCV pharmacological treatment : Client and staff perspectives
Failed retrieving data."Informed Altruism" and "Partner Restriction" in the Reduction of HIV Infection in Injecting Drug Users Entering Detoxification Treatment in New York City, 1990-2001
Failed retrieving data.A comparison of HCV antibody testing in drug-free and methadone maintenance treatment programs in the United States
Failed retrieving data.Drug treatment programs as sites of opportunity for the delivery of hepatitis C prevention education : Client and staff perspectives
Failed retrieving data.Hepatitis C virus infection among injection drug users : Survival analysis of time to seroconversion
Failed retrieving data.Highly active antiretroviral therapy for injection drug users : Physician-recommended strategies for enhanced adherence
Failed retrieving data.Outpatient drug treatment program directors' hepatitis C-related beliefs and their relationship to the provision of HCV services
Failed retrieving data.Screening for depressive symptoms among HCV-infected injection drug users : Examination of the utility of the CES-D and the Beck Depression Inventory
Failed retrieving data.The Content and Comprehensiveness of Hepatitis C Education in Methadone Maintenance and Drug-Free Treatment Units
Failed retrieving data.Depression and HIV risk behavior among Seattle-area injection drug users and young men who have sex with men
Failed retrieving data.Does bleach disinfection of syringes help prevent hepatitis C virus transmission? [1] (multiple letters)
Failed retrieving data.Gaps in the drug-free and methadone treatment program response to Hepatitis C
Failed retrieving data.